ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Bypass Budget For FY Seeks $1.189 Billion, Would Fund 1,018 Competing Grants, Restore Cuts

May 20, 1983

CPRU Program Gets Basic Concept Approval

October 2, 1987

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Another Potti Paper Retracted

September 16, 2011

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

Byrd Permits NCI to Reallocate WVU Money

June 21, 1985